These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 8024164

  • 1. Comparative evaluation of pentoxifylline, buflomedil, and nifedipine in the treatment of intermittent claudication of the lower limbs.
    Chacón-Quevedo A, Eguaras MG, Calleja F, Garcia MA, Roman M, Casares J, Muñoz I, Concha M.
    Angiology; 1994 Jul; 45(7):647-53. PubMed ID: 8024164
    [Abstract] [Full Text] [Related]

  • 2. Pentoxifylline for intermittent claudication.
    Salhiyyah K, Forster R, Senanayake E, Abdel-Hadi M, Booth A, Michaels JA.
    Cochrane Database Syst Rev; 2015 Sep 29; 9(9):CD005262. PubMed ID: 26417854
    [Abstract] [Full Text] [Related]

  • 3. The effects of prostaglandin E-1 in patients with intermittent claudication.
    Milio G, Coppola G, Novo S.
    Cardiovasc Hematol Disord Drug Targets; 2006 Jun 29; 6(2):71-6. PubMed ID: 16787192
    [Abstract] [Full Text] [Related]

  • 4. Pentoxifylline for intermittent claudication.
    Salhiyyah K, Senanayake E, Abdel-Hadi M, Booth A, Michaels JA.
    Cochrane Database Syst Rev; 2012 Jan 18; 1():CD005262. PubMed ID: 22258961
    [Abstract] [Full Text] [Related]

  • 5. Buflomedil for intermittent claudication.
    De Backer TL, Vander Stichele RH, Bogaert MG.
    Cochrane Database Syst Rev; 2001 Jan 18; (1):CD000988. PubMed ID: 11279700
    [Abstract] [Full Text] [Related]

  • 6. A placebo-controlled study of the effects of intravenous Buflomedil on foot skin microcirculation in patients with severe intermittent claudication.
    Van den Brande P, Maurel A.
    Angiology; 1998 Feb 18; 49(2):105-14. PubMed ID: 9482510
    [Abstract] [Full Text] [Related]

  • 7. Treatment of intermittent claudication with pentoxifylline: a 12-month, randomized trial--walking distance and microcirculation.
    De Sanctis MT, Cesarone MR, Belcaro G, Nicolaides AN, Griffin M, Incandela L, Bucci M, Geroulakos G, Ramaswami G, Vasdekis S, Agus G, Bavera P, Ippolito E.
    Angiology; 2002 Feb 18; 53 Suppl 1():S7-12. PubMed ID: 11865838
    [Abstract] [Full Text] [Related]

  • 8. Treatment of long-distance intermittent claudication with pentoxifylline: a 12-month, randomized trial.
    De Sanctis MT, Cesarone MR, Belcaro G, Nicolaides AN, Griffin M, Incandela L, Bucci M, Geroulakos G, Ramaswami G, Vasdekis S, Agus G, Bavera P, Ippolito E.
    Angiology; 2002 Feb 18; 53 Suppl 1():S13-7. PubMed ID: 11865829
    [Abstract] [Full Text] [Related]

  • 9. A randomized trial of iloprost in patients with intermittent claudication.
    Creager MA, Pande RL, Hiatt WR.
    Vasc Med; 2008 Feb 18; 13(1):5-13. PubMed ID: 18372433
    [Abstract] [Full Text] [Related]

  • 10. Short-range intermittent claudication and rest pain: microcirculatory effects of pentoxifylline in a randomized, controlled trial.
    Incandela L, De Sanctis MT, Cesarone MR, Belcaro G, Nicolaides AN, Geroulakos G, Ramaswami G.
    Angiology; 2002 Feb 18; 53 Suppl 1():S27-30. PubMed ID: 11865832
    [Abstract] [Full Text] [Related]

  • 11. Failure of pentoxifylline or cilostazol to improve blood and plasma viscosity, fibrinogen, and erythrocyte deformability in claudication.
    Dawson DL, Zheng Q, Worthy SA, Charles B, Bradley DV.
    Angiology; 2002 Feb 18; 53(5):509-20. PubMed ID: 12365857
    [Abstract] [Full Text] [Related]

  • 12. Effects of cilostazol and pentoxifylline on forearm reactive hyperemia response, lipid profile, oxidative stress, and inflammatory markers in patients with intermittent claudication.
    de Albuquerque RM, Virgini-Magalhães CE, Lencastre Sicuro F, Bottino DA, Bouskela E.
    Angiology; 2008 Feb 18; 59(5):549-58. PubMed ID: 18388031
    [Abstract] [Full Text] [Related]

  • 13. A comparison of cilostazol and pentoxifylline for treating intermittent claudication.
    Dawson DL, Cutler BS, Hiatt WR, Hobson RW, Martin JD, Bortey EB, Forbes WP, Strandness DE.
    Am J Med; 2000 Nov 18; 109(7):523-30. PubMed ID: 11063952
    [Abstract] [Full Text] [Related]

  • 14. Treatment of severe intermittent claudication with pentoxifylline: a 40-week, controlled, randomized trial.
    Cesarone MR, Belcaro G, Nicolaides AN, Griffin M, De Sanctis MT, Incandela L, Geroulakos G, Ramaswami G, Cazaubon M, Barsotti A, Vasdekis S, Bavera P, Ippolito E.
    Angiology; 2002 Nov 18; 53 Suppl 1():S1-5. PubMed ID: 11865828
    [Abstract] [Full Text] [Related]

  • 15. Improving walking ability and ankle brachial pressure indices in symptomatic peripheral vascular disease with intermittent pneumatic foot compression: a prospective controlled study with one-year follow-up.
    Delis KT, Nicolaides AN, Wolfe JH, Stansby G.
    J Vasc Surg; 2000 Apr 18; 31(4):650-61. PubMed ID: 10753272
    [Abstract] [Full Text] [Related]

  • 16. A comparison between aspirin and pentoxifylline in relieving claudication due to peripheral vascular disease in the elderly.
    Ciocon JO, Galindo-Ciocon D, Galindo DJ.
    Angiology; 1997 Mar 18; 48(3):237-40. PubMed ID: 9071199
    [Abstract] [Full Text] [Related]

  • 17. Cost effectiveness of cilostazol compared with naftidrofuryl and pentoxifylline in the treatment of intermittent claudication in the UK.
    Guest JF, Davie AM, Clegg JP.
    Curr Med Res Opin; 2005 Jun 18; 21(6):817-26. PubMed ID: 15969881
    [Abstract] [Full Text] [Related]

  • 18. Buflomedil in arterial occlusive disease: results of a controlled multicenter study.
    Trübestein G, Balzer K, Bisler H, Klüken N, Muller-Wiefel H, Unkel B, Mahfoud Y, Ziegler W.
    Angiology; 1984 Aug 18; 35(8):500-5. PubMed ID: 6383127
    [Abstract] [Full Text] [Related]

  • 19. Clinical and hemorheological effects of buflomedil in diabetic subjects with intermittent claudication.
    Diamantopoulos EJ, Grigoriadou M, Ifanti G, Raptis SA.
    Int Angiol; 2001 Dec 18; 20(4):337-44. PubMed ID: 11782701
    [Abstract] [Full Text] [Related]

  • 20. Cilostazol has beneficial effects in treatment of intermittent claudication: results from a multicenter, randomized, prospective, double-blind trial.
    Dawson DL, Cutler BS, Meissner MH, Strandness DE.
    Circulation; 1998 Aug 18; 98(7):678-86. PubMed ID: 9715861
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.